"„МБАЛ Св. Панталеймон – Плевен” ООД разполага с водещата в централна и северна България Клиника по ортопедия и травматология. В нея се извършват гръбначна хирургия, артроскопска хирургия и детска ортопедия. Болницата има договор със Здравната каса и работи по клинични пътеки. Пациентите могат да избират ВИП условия (самостоятелна стая и консумативи) срещу допълнително заплащане."

During the past decade, MHAT "Sv. Pantaleymon - Pleven", OOD conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MHAT "Sv. Pantaleymon - Pleven", OOD" #1 sponsor was "Intec Pharma Ltd." with 2 trials, followed by "ThromboGenics" with 2 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "Esperion Therapeutics, Inc." with 1 trials sponsored and "Galapagos NV" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MHAT "Sv. Pantaleymon - Pleven", OOD" #1 collaborator was "BioInvent International AB" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Covance" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "MHAT "Sv. Pantaleymon - Pleven", OOD" are "Parkinson's Disease" (2 trials), "Ulcerative Colitis" (2 trials), "Atrial Fibrillation" (1 trials), "Cardiovascular Diseases" (1 trials) and "Dyslipidemia" (1 trials). Many other conditions were trialed in "MHAT "Sv. Pantaleymon - Pleven", OOD" in a lesser frequency.

Most popular intervention types in "MHAT "Sv. Pantaleymon - Pleven", OOD" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Accordion Pill™ Carbidopa/Levodopa" (2 trials), "Filgotinib" (2 trials), "Placebo" (2 trials), "TB-402" (2 trials) and "Bempedoic acid 180 mg tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "MHAT "Sv. Pantaleymon - Pleven", OOD" are 9 trials for "All" genders.

Currently, there are NaN active trials in "MHAT "Sv. Pantaleymon - Pleven", OOD". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in MHAT "Sv. Pantaleymon - Pleven", OOD, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MHAT "Sv. Pantaleymon - Pleven", OOD, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".